Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review
<i>Background</i>: Cardiac rhabdomyomas (CRs) are the most common cardiac tumors in newborns. Approximately 80-90% of cases are associated with tuberous sclerosis complex (TSC). In selective cases, Everolimus has resulted in a remarkable tumoral regression effect in children with TS. The...
Saved in:
Main Authors: | Luisa Federica Nespoli (Author), Elena Albani (Author), Carla Corti (Author), Luigina Spaccini (Author), Enrico Alfei (Author), Irene Daniele (Author), Gian Vincenzo Zuccotti (Author), Gianluca Lista (Author), Valeria Calcaterra (Author), Savina Mannarino (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus
by: Roberto Previtali, et al.
Published: (2023) -
Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
by: Yuka Shibata, et al.
Published: (2019) -
Intracardiac rhabdomyoma in a newborn with tuberous sclerosis
by: I Kadek Suarca, et al.
Published: (2016) -
Cardiac rhabdomyomas as prenatal diagnostic markers of tuberous sclerosis complex
by: Virginia Ruth Lopez Gamboa, et al.
Published: (2023) -
Successful Prenatal Treatment of Cardiac Rhabdomyoma in a Fetus with Tuberous Sclerosis
by: Joachim Carsten Will, et al.
Published: (2023)